SLNO - Soleno Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2026-02-10)
Last
 40.50		 Change
 ⇓ -0.38   (-0.93%)		 Volume
  776,011
Open
 40.98		 High
 41.84		 Low
 40.38
8EMA (Daily)
 41.22		 40EMA (Daily)
 44.65		 50EMA (Daily)
 45.87		 STO (Daily)
 51.213		 MACD Hist (Daily)
 0.053
8EMA (Weekly)
 42.756		 40EMA (Weekly)
 54.84		 50EMA (Weekly)
 55.49		 STO (Weekly)
 7.858		 MACD Hist (Weekly)
 -0.010
Company Profile
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com